The changing multiple sclerosis treatment landscape: impact of new drugs and treatment recommendations

PURPOSE: The purpose of this study is to describe the utilization of disease-modifying treatments (DMTs) in relapsing-remitting multiple sclerosis (MS) and assess the impact of both the introduction of new drugs and treatment recommendations (local recommendation on rituximab use issued at the large...

Descripción completa

Detalles Bibliográficos
Autores principales: Eriksson, Irene, Komen, Joris, Piehl, Fredrik, Malmström, Rickard E., Wettermark, Björn, von Euler, Mia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Pharmacoepidemiology and Prescription
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893684/
https://www.ncbi.nlm.nih.gov/pubmed/29429031
http://dx.doi.org/10.1007/s00228-018-2429-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893684/
https://www.ncbi.nlm.nih.gov/pubmed/29429031
http://dx.doi.org/10.1007/s00228-018-2429-1

Ejemplares similares